Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 191 (RN7SKP191) is a predicted pseudogene based on homology to the RN7SK gene, which encodes the RNA component of the 7SK small nuclear ribonucleoprotein. Pseudogenes are generally the result of gene duplication or retrotransposition events leading to copies that are no longer functional—typically due to mutations or lack of required regulatory sequences[3][7]. There is no evidence suggesting RN7SKP191 is expressed or participates in any biological processes, nor has it been implicated as a therapeutic target, disease gene, or biomarker. Its existence is of genomic annotation interest only and not a subject of current biomedical research targeting[3][7]. Clarification: - If you are seeking information on the biologically active non-coding RNA RN7SK (not the pseudogene), this is a well-studied lncRNA with important regulatory functions in transcription elongation and disease, but RN7SKP191 itself lacks described function[1][6]. - Most "pseudogene" entries in the human genome (especially those named like RN7SKPxxx) are non-functional and not druggable or biologically active[7]. Summary Statement: RN7SK pseudogene 191 (RN7SKP191) is a non-functional genomic sequence related to the 7SK non-coding RNA and is not considered a therapeutic target or biologically relevant molecule in current knowledge[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 191 (RN7SKP191).